Management of Adrenal Surges in Dysautonomia
The term "adrenal dumps" in dysautonomia typically refers to inappropriate catecholamine surges causing symptoms like tachycardia, palpitations, and anxiety, rather than true adrenal insufficiency—the primary treatment approach focuses on beta-blockers, volume expansion with fludrocortisone, and increased salt/fluid intake to stabilize autonomic dysfunction.
Understanding the Clinical Context
Dysautonomia encompasses conditions like POTS (Postural Orthostatic Tachycardia Syndrome) where patients experience excessive sympathetic activation and catecholamine release. This is fundamentally different from adrenal insufficiency, though both involve the adrenal system 1, 2.
Key distinction: If you're seeing a patient with dysautonomia experiencing episodic "adrenaline surges" (tachycardia, tremor, anxiety, palpitations), this represents autonomic nervous system dysfunction, not adrenal crisis.
Primary Treatment Strategy
First-Line Pharmacologic Interventions
Beta-adrenergic blocking agents are the cornerstone for controlling excessive sympathetic surges in dysautonomia 1, 2. These directly block the effects of catecholamine release.
Fludrocortisone (0.1-0.2 mg daily) serves a critical role in dysautonomia by:
- Expanding intravascular volume
- Reducing orthostatic stress that triggers compensatory catecholamine release
- Improving blood pressure stability 3, 1
Essential Non-Pharmacologic Measures
Volume expansion is mandatory 3, 2:
- Salt intake: 2-3 grams additional sodium daily (beyond normal diet)
- Fluid intake: 2-2.5 liters per day minimum
- These measures reduce the physiologic stress that triggers excessive sympathetic activation
Physical countermaneuvers 3:
- Leg crossing and squatting when symptoms occur
- Compression garments (waist-high stockings, abdominal binders)
- Elevate head of bed 20-30 cm to reduce nocturnal pressure natriuresis
Additional Pharmacologic Options
Midodrine (alpha-agonist) can be added if beta-blockers and fludrocortisone are insufficient, though it may paradoxically worsen some symptoms by increasing sympathetic tone 3, 1.
Ivabradine and pyridostigmine represent alternative agents for heart rate control in POTS-type dysautonomia 1.
Critical Pitfall: Distinguishing from True Adrenal Crisis
Do not confuse dysautonomic surges with adrenal insufficiency. True adrenal crisis presents with:
- Hypotension (not hypertension)
- Hyponatremia and hyperkalemia
- Profound weakness and altered mental status
- Requires immediate hydrocortisone 100 mg IV 4, 5
If a patient with dysautonomia is on chronic glucocorticoids (≥5 mg prednisolone equivalent for >1 month), they may have HPA axis suppression and require stress-dose steroids during illness—but this is separate from managing autonomic surges 6.
Monitoring and Adjustment
Clinical parameters to track:
- Orthostatic vital signs (blood pressure and heart rate at 1,3,5, and 10 minutes of standing)
- Symptom frequency and severity
- For fludrocortisone: monitor for hypertension, edema, hypokalemia (signs of overdose) 7
Common mistake: Over-treating with fludrocortisone can cause supine hypertension. If blood pressure exceeds 160/90 mmHg supine, consider dose reduction or short-acting antihypertensives at bedtime 2.
When Symptoms Persist
If standard therapy fails:
- Reassess medication compliance and salt/fluid intake
- Consider autonomic function testing (tilt table, Valsalva maneuver) to characterize the specific dysautonomic pattern 2
- Evaluate for underlying causes: diabetes, autoimmune conditions, vitamin deficiencies 1
- Referral to autonomic disorder specialist may be warranted
The goal is symptom control and improved quality of life—there is no cure for most forms of dysautonomia, so treatment focuses on reducing the frequency and severity of autonomic surges 2, 8.